Stent

Silk Road Medical announced that it has launched the next iteration of its transcarotid stent system in the U.S.

W. L. Gore and Associates announced the FDA approved of its low-profile balloon expandable stent for treatment of iliac artery de novo or restenotic lesions with reference vessel diameters of 5 to 13 mm and lesion length up to 110 mm.

SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI, data presented at TCT 2023 show.

An integrated carotid artery stent system was associated with the lowest 1-year event rates in any well-powered, multicenter carotid revascularization trial, according to data presented at VIVA.23.

SAN FRANCISCO — A biodegradable polymer sirolimus-eluting stent remained superior to a durable polymer everolimus-eluting stent for treating STEMI at 5 years, a difference driven by lower rates of ischemia-driven repeat revascularizations.

A stent graft for abdominal aortic aneurysm repair was associated with durable performance and low rates of aneurysm-related mortality at 10 years, researchers reported at the Charing Cross Symposium.

In patients with ACS, there were no differences in 5-year risk for cardiac death, MI or target lesion revascularization for those who received titanium-nitride-oxide-coated stents vs. biodegradable polymer drug-eluting stent, data show.

A novel 48-mm stent for the treatment of diffuse de novo coronary artery lesions was found to be safe and effective at 1 year, with a high level of device deliverability, a speaker reported.

Comparing single antiplatelet therapy after 3-month DAPT with 12-month DAPT after PCI with third-generation DES with the thinnest struts.

A second non-implant MIGS intervention, namely canaloplasty and trabeculotomy, allows patients to achieve good IOP control if a prior trabecular micro-bypass stent has failed to maintain IOP as desired.